Abstract 4368688: PERM1 Enhances Cardiac Contractility via Sarcomeric Metabolic Integration and Downregulation of MYBPC3

Background: Heart failure with reduced ejection fraction (HFrEF) affects over 3 million adults in the United States and is associated with high morbidity and mortality, with five-year survival rates below 50%. HFrEF is characterized by impaired myocardial contractility and energy metabolism, with disrupted coupling between sarcomeric force production and energy transduction, known as mechano-energetics. Our previous study demonstrated that adeno-associated virus (AAV)-mediated gene delivery of PERM1, a striated muscle-specific regulator of mitochondrial bioenergetics, enhances cardiac contractility in mice, underscoring its therapeutic potential in HFrEF. However, the mechanisms by which PERM1 modulates myocardial contractility remain largely unknown. Hypothesis: We hypothesized that PERM1 enhances cardiac contractility via a non-canonical mechanism by acting as a signaling nexus that links metabolic regulation to sarcomeric function. Methods and Results: Bioinformatic analysis of mass spectrometry-based screening identified myosin-binding protein C3 (MYBPC3), a cardiac-specific regulator that limits actin-myosin cross-bridge formation, as a PERM1-interacting protein. Co-immunoprecipitation confirmed interactions of PERM1 with both MYBPC3 and creatine kinase B (CKB), a stress-responsive isoform essential for ATP delivery to the sarcomere. Super-resolution stochastic optical reconstruction microscopy (STORM) revealed complexing of CKB with troponin C in cardiomyocytes from AAV-PERM1-treated hearts, which was markedly reduced in PERM1-null hearts (Figure 1). Furthermore, MYBPC3 expression was significantly decreased in AAV–PERM1–treated hearts (74.2% reduction vs. AAV-GFP controls, p<0.01). Conclusions: These findings suggest that PERM1 enhances cardiac contractility by downregulating MYBPC3 to promote actin-myosin interactions and by anchoring CKB to the sarcomere to couple energy metabolism with contractile function. Collectively, our data uncover a novel role for PERM1 in regulating myocardial contractility through direct sarcomeric metabolic integration.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4368688
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4368688: PERM1 Enhances Cardiac Contractility via Sarcomeric Metabolic Integration and Downregulation of MYBPC3

Karthi Sreedevi, James W. Smyth, Alexey V. Zaitsev, Junco S. Warren et al.
Circulation
Cardiomyopathy and Myosin Studies
article

Abstract 4368688: PERM1 Enhances Cardiac Contractility via Sarcomeric Metabolic Integration and Downregulation of MYBPC3

Karthi Sreedevi, James W. Smyth, Alexey V. Zaitsev, Junco S. Warren, Sarah Salama, Abigail Oforiwaa Doku, Rebekah Thomas
article en

Abstract

Background: Heart failure with reduced ejection fraction (HFrEF) affects over 3 million adults in the United States and is associated with high morbidity and mortality, with five-year survival rates below 50%. HFrEF is characterized by impaired myocardial contractility and energy metabolism, with disrupted coupling between sarcomeric force production and energy transduction, known as mechano-energetics. Our previous study demonstrated that adeno-associated virus (AAV)-mediated gene delivery of PERM1, a striated muscle-specific regulator of mitochondrial bioenergetics, enhances cardiac contractility in mice, underscoring its therapeutic potential in HFrEF. However, the mechanisms by which PERM1 modulates myocardial contractility remain largely unknown. Hypothesis: We hypothesized that PERM1 enhances cardiac contractility via a non-canonical mechanism by acting as a signaling nexus that links metabolic regulation to sarcomeric function. Methods and Results: Bioinformatic analysis of mass spectrometry-based screening identified myosin-binding protein C3 (MYBPC3), a cardiac-specific regulator that limits actin-myosin cross-bridge formation, as a PERM1-interacting protein. Co-immunoprecipitation confirmed interactions of PERM1 with both MYBPC3 and creatine kinase B (CKB), a stress-responsive isoform essential for ATP delivery to the sarcomere. Super-resolution stochastic optical reconstruction microscopy (STORM) revealed complexing of CKB with troponin C in cardiomyocytes from AAV-PERM1-treated hearts, which was markedly reduced in PERM1-null hearts (Figure 1). Furthermore, MYBPC3 expression was significantly decreased in AAV–PERM1–treated hearts (74.2% reduction vs. AAV-GFP controls, p<0.01). Conclusions: These findings suggest that PERM1 enhances cardiac contractility by downregulating MYBPC3 to promote actin-myosin interactions and by anchoring CKB to the sarcomere to couple energy metabolism with contractile function. Collectively, our data uncover a novel role for PERM1 in regulating myocardial contractility through direct sarcomeric metabolic integration.

CirculationVol. 152(Suppl_3)
Virginia Tech (US)
Openalex Percentile: Top 50%
Cardiomyopathy and Myosin Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.